S-1/A: Mitesco, Inc. Files Amendment to S-1 Registration for Resale of 15.3 Million Common Shares

Mitesco, Inc. is filing an amendment to its S-1 registration statement to allow selling stockholders to resell up to 15,278,771 shares of common stock.

Summary

• Mitesco, Inc., a Nevada corporation, has filed an amendment to its Form S-1 registration statement with the SEC.
• The registration statement covers the resale of up to 15,278,771 shares of the company's common stock by selling stockholders.
• These shares consist of (i) 2,628,179 shares issued in connection with debt restructuring, (ii) 9,978,907 shares issuable upon redemption of Series A Preferred Stock, and (iii) 2,671,685 shares previously issued in unregistered offerings.
• Mitesco will not receive any proceeds from the sale of these shares.
• The company is a smaller reporting company and may elect to comply with reduced public company reporting requirements.
• Investing in the common stock is highly speculative and involves a high degree of risk.
• The common stock is currently traded on the Pink Market of the OTC under the symbol MITI, with a last reported bid price of $0.32 on May 6, 2025.
• The company's business operations now include Centcore, LLC (datacenter services) and Vero Technology Ventures, LLC (investment and acquisition opportunities in cloud computing).
• The company is developing a sales automation tool set deemed the Robo Agent application, expected to be available for initial users in Q3 of FY2025.
• The company has instituted a new Advisory Board whose participants include subject matter experts in certain business areas under consideration by the Company.
• The company has converted approximately $26.5 million of its obligations into 2,628,179 shares of restricted Common Stock, and 562,998 Series A Preferred stock.
• The company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC for total consideration of approximately $2.5 million.
• There is substantial doubt about the ability of the Company to continue as a going concern for one year from the date the financial statements are issued.
• The company had revenues of $43,700 for the twelve months ended December 31, 2024, compared to $0 in the comparable period.
• For the twelve months ended December 31, 2024, we had an overall net loss available to common shareholders of $2,842,256, compared to a net loss available to common shareholders of $15,052,144 for the twelve months ended December 31, 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is making efforts to restructure its debt and explore new business opportunities, the financial situation remains precarious with a going concern warning and significant losses. The sentiment is cautiously negative.

Positives

• The company has successfully restructured approximately $26.5 million of its obligations.
• The company has formed two new business units, Centcore, LLC and Vero Technology Ventures, LLC, to focus on datacenter services and cloud computing investments.
• The company is developing a new sales automation tool using A.I. (Robo Agent) expected to be available for initial users in Q3 of FY2025.
• The company has formed an Advisory Board with subject matter experts to assist in business development.
• The company has generated revenues of $43,700 for the twelve months ended December 31, 2024, compared to $0 in the comparable period.
• The company has reduced its net loss available to common shareholders from $15,052,144 to $2,842,256.

Negatives

• The company has a history of losses and has nominal revenues from its operations.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company has current liabilities of approximately $18.4 million and limited cash on hand.
• The company has identified weaknesses in its internal controls.
• The company's stock price has been volatile and may be volatile in the future.
• The company's Common Stock has often been thinly traded, so investors may be unable to sell at or near ask prices or at all if investors need to sell shares to raise money or otherwise desire to liquidate their shares.

Risks

• The company is in the initial stages of its present business plan and has a limited historical performance.
• The company may be unable to attract and retain sufficient numbers of qualified personnel.
• The company is in an intensely competitive industry.
• Rapid technological change in the industry presents significant risks and challenges.
• The company may be unable to generate significant revenue or secure financing.
• The company may incur additional debt in the future which may contain restrictive covenants.
• The issuance of additional shares of common stock may dilute the percentage ownership of existing stockholders.
• Privacy concerns and laws may limit the use and adoption of the company's services.
• Acquisitions may subject the company to liability with regard to the creditors, customers, and shareholders of the sellers.
• Redemption of all shares of Series A Preferred Stock into Common Stock may lead to severe dilution of our existing shares.
• Resales of our Common Stock in the public market by our stockholders as a result of this offering may cause the market price of our Common Stock to fall.
• If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, or are perceived to have been compromised, we could experience adverse consequences.

Future Outlook

The company is seeking to pursue near-term opportunities, assuming the capital markets make sufficient funding available at reasonable rates. The company is developing a sales automation tool set deemed the Robo Agent application, expected to be available for initial users in Q3 of FY2025.

Industry Context

The company is operating in the datacenter services and cloud computing industry, which is a highly competitive and rapidly evolving market. The company faces competition from in-house IT departments, traditional IT systems integrators, cloud service providers, and colocation providers.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the document does mention that the company faces competition from larger, more established companies such as Accenture, Atos, Capgemini, Cognizant, Deloitte, DXC Technology and IBM.
• These companies have greater financial, technical, and marketing resources, larger global presence, larger customer bases, longer operating histories, greater brand recognition, and more established relationships in the industry than Mitesco does.

Legal Proceedings

• The Company has a number of legal situations involved with the winding down of its clinic business activities.
• These include claims regarding certain construction contracts and cancellation of leases.

Related Party Transactions

• On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC for total consideration of approximately $2.5 million.
• During Q4 of 2024, as a part of the 2024 Debt Restructuring, Mr. Howe has exchanged all remaining obligations into restricted common stock using a $4 per share valuation.
• The Company acquired, subject to certain payment milestones, the source code and business activities of AgingTopic, which constitutes substantially all of AgingTopics assets utilized in the creation of advertising revenue from blog postings. The entity that owns the business and source code is controlled by Ms. Amy Lance, the wife of Mack Leath.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of common stock for debt restructuring and redemption of preferred stock.
• Employees are not directly impacted as the company currently has no full-time employees.
• Customers may benefit from the company's new business units and technology development.
• Suppliers and creditors are impacted by the company's debt restructuring and settlement agreements.

Next Steps

• The company intends to redeem the Series A Preferred shares using common stock for the foreseeable future.
• The company is continuing an effort to negotiate a settlement of any remaining obligations to Gardner.
• The Company is undertaking to change its trading platform from the OTC Pink Market on to the OTCQB Venture Market at which time its shares will be quoted in a form more acceptable to the marketplace.

Key Dates

Keywords

common stock, registration statement, resale, Series A Preferred Stock, debt restructuring, Centcore, Vero Technology Ventures, Robo Agent, Advisory Board, going concern, risk factors, financial condition, cybersecurity